Andrew Barkmeier MD (@AndrewBarkmeier) header
Andrew Barkmeier MD (@AndrewBarkmeier) profile picture

Ophthalmologist & Vitreoretinal Surgeon @MayoClinicEye @MayoClinic

Joined November 2015
Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)Photo by Andrew Barkmeier MD (@AndrewBarkmeier)
🤷🏼‍♂️Any difference between intravitreal antiVEGF meds in risk of systemic SAEs? We report real world data on 87,844 pts starting antiVEGF💉👁 👩🏻‍⚕️: NO difference in risk of 💔,🧠,🩸, or 🏥 after bevacizumab, ranibizumab, or aflibercept Check it out! #retina
Large database study showed no difference in the rate of cerebrovascular disease, myocardial infarction, major bleeding, or hospitalization following intravitreal injections of bevacizumab, ranibizumab, or aflibercept for retinal conditions ow.ly/nm2d50AYSWT
4
12
2
64
DRCR Retina Network @DrcrNet is certifying new clinical trial sites and enrolling patients for two important RCTs with surgical treatment arms: Protocol AM for symptomatic ERM Protocol AP for moderate PDR Reach out to: [email protected] to get involved!
Are you interested in DRCR research? Andrew J. Barkmeier, MD, shared information on Protocols AM and AP, and how to get involved. @YoungMDConnect @VitBuckleSoc #VBSinWonderland #retina
165
Yes, recommend eye protection👍 We’re seeing an increasing number of vision-threatening pickleball eye injuries
A couple of important lessons to be learned here… 1) There’s zero reason to full-send a popup at your opponent when he’s down on the ground. That ball could have been put away a hundred different ways rather than hitting it as hard as you can directly at the guy. 2) This is a perfect example of why eye protection matters. At the very least wear a forwards hat to give your eyes some protection. The kid thankfully walked away with no serious damage, dabbed it up, and showed good sportsmanship. This could have ended very badly. 😬
3
88
GLP-1 RA and SGLT2i medications have significant cardiovascular benefits. How do they impact the risk of diabetic macular edema and proliferative diabetic retinopathy?
New study looks at the comparative effectiveness of GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, and sulfonylureas for sight-threatening #diabeticretinopathy. @AndrewBarkmeier @RozalinaMD ow.ly/MykX50RMZtO
1
3
607
SGLT2i use was associated with a lower risk of DME+PDR compared to other glucose-lowering therapies GLP-1 RA agents did not increase retinal risk compared to DPP-4i or sulfonylurea
1
98
Does a scleral buckle lower the risk of glaucoma? How does scleral buckling impact ocular biomechanics? podcasts.apple.com/us/podcas…
1
1
156
👨‍⚕️ “… and you shouldn’t lift anything heavy for the next week” “What about my pet raccoon? She’s about 40 pounds.” 👨‍⚕️“oh… really… yeah, not this week”
1
12
875
BLIP origin story 👍
What does BLIP stand for in ophthalmology? @DrewCareyMD and Dr. Aaron Nagiel chat about benign intraretinal tumors and the coining of the term “benign lobular inner nuclear layer proliferation,” aka BLIPs. #OphthalmologyJournal #podcast @USCEye ow.ly/w25g50OuZn5
3
421
For rising M4s applying to ophthalmology, rotating at different institutions offers another lens through which to appreciate this amazing specialty 👁️ And the similarities/differences between training environments can help sort out what will help YOU thrive See you this fall!
This Post is from a suspended account. Learn more
1
1
17
3,842
Replying to @DrcrNet
@DrcrNet Protocol W 4 year results: For mod-sev NPDR, q4 mon intravitreal antiVEGF offered no visual acuity benefit vs treating only if complications developed @rmaturi ja.ma/3JKVJOB
2
5
309
Characteristics and outcomes of novel OCT finding: Foveal Herniation in pts with ERM Well done @SaumyaMShahMD @allenho @YoshiYonekawaMD @RayIezziMD and collaborators
EPIRETINAL MEMBRANE WITH FOVEAL HERNIATION Visual and Surgical Outcomes Shah, Saumya M. MD; et. al. Retina 43(2):p 182-190, February 2023 journals.lww.com/retinajourn… #retina
1
5
1,303
Welcome! We’re looking forward to meeting the whole growing family!
Couldn’t be happier to announce that I matched into ophthalmology residency at @MayoClinicEye, @TSmithMcinnis passed his veterinary licensing boards, and we’ll be moving to Rochester, MN…as a family of FIVE! Twins McSmith due in a few short weeks! #eyematched #match2023 #aaoyo
9
1,278
Welcome to @MayoClinicEye! We can’t wait to work with all of you! #Match2023 #EyeMatched #aaoyo
This Post is from a suspended account. Learn more
1
2
1
27
4,959
Welcome to @MayoClinicEye!
I’m going to be an ophthalmologist!!! So excited to have matched at @MayoClinicEye!!!
12
1,286
Highly recommend the @aao_ophth Minority Ophthalmology Mentoring program! Learn more about our amazing specialty and help save vision every day!
#URiM Medical Students: interested in pursuing career in #Ophthalmology — Checkout/Apply to the @aao_ophth Mentoring program - Apply Online online by January 31: aao.org/minority-mentoring #MedStudentTwitter #MedEd #MedStudents #InsideTheMatch #MedStudentTwitter #OphthoTwitter
2
1
10
1,831
And that’s a wrap for @mayocliniceye 2022 virtual interviews…   This sweet rig with repurposed desk lamp, scotch tape, & brown napkins has done the trick since summer 2020 👍 No doubt this #Ophthalmology class of 2027 is going to move the needle - welcome!
1
22
Ever see a BLIP? Linked up with Dr Aaron Nagiel and collaborators to report several cases of INL lesions sharing this striking OCT appearance
Benign Lobular Inner nuclear layer Proliferation (BLIP) is a newly described benign intraretinal tumor which can be associated with congenital hypertrophy of the retinal pigment epithelium ow.ly/ySSI50LlgCW
1
5
Superstar @MayoClinicEye residents @SaumyaMShahMD and Blake Fortes, MD presenting their research @RetinaSociety 2022 Annual Meeting
4
26
Dr. Raj Maturi presents @DrcrNet Protocol W 4 year results @RetinaSociety 2022 Preventative antiVEGF for mod-sev NPDR did NOT benefit vision at 4y (vs. observation + PRN rescue antiVEGF)
1
1
9